Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark C Enright

Showing results (11-20 of 57) with videos related to

Pageof 6
Sort By:
Journal of Clinical Microbiology|May 6, 2005
Genetic background affects stability of mecA in Staphylococcus aureusYuki Katayama, D Ashley Robinson, Mark C Enright, et al.
Microbiology (Reading, England)|August 27, 1999
Serotype 14 variants of the Spanish penicillin-resistant serotype 9V clone of Streptococcus pneumoniae arose by large recombinational replacements of the cpsA-pbp1a regionTracey J Coffey, Margaret Daniels, Mark C Enright, et al.
Infection and Immunity|March 16, 2002
Influence of recombination and niche separation on the population genetic structure of the pathogen Streptococcus pyogenesAwdhesh Kalia, Brian G Spratt, Mark C Enright, et al.
Expert Review of Anti-Infective Therapy|September 13, 2011
Bacteriophage therapy: potential uses in the control of antibiotic-resistant pathogensBen Burrowes, David R Harper, Joseph Anderson, et al.
Emerging Infectious Diseases|June 18, 2004
Vancomycin susceptibility within methicillin-resistant Staphylococcus aureus lineagesRobin A Howe, Alastair Monk, Mandy Wootton, et al.
Antimicrobial Agents and Chemotherapy|April 28, 2005
Seven novel variants of the staphylococcal chromosomal cassette mec in methicillin-resistant Staphylococcus aureus isolates from IrelandAnna Shore, Angela S Rossney, Conor T Keane, et al.
Antimicrobial Agents and Chemotherapy|October 25, 2003
Related clones containing SCCmec type IV predominate among clinically significant Staphylococcus epidermidis isolatesHilmar Wisplinghoff, Adriana E Rosato, Mark C Enright, et al.
The Journal of Antimicrobial Chemotherapy|December 2, 2005
In vitro activity of a novel compound, the metal ion chelating agent AQ+, against clinical isolates of Staphylococcus aureusBenjamin R D Short, Miguel A Vargas, Jonathan C Thomas, et al.
Journal of Molecular and Genetic Medicine : an International Journal of Biomedical Research|August 9, 2012
The role of regulated clinical trials in the development of bacteriophage therapeuticsHelena Mrt Parracho, Ben H Burrowes, Mark C Enright, et al.
Journal of Bacteriology|December 3, 2005
Evolutionary genetics of the accessory gene regulator (agr) locus in Staphylococcus aureusD Ashley Robinson, Alastair B Monk, Jessica E Cooper, et al.
Pageof 6

Showing results (11-20 of 57) with videos related to

Sort By:
Pageof 6
Journal of Clinical Microbiology|May 6, 2005
Genetic background affects stability of mecA in Staphylococcus aureusYuki Katayama, D Ashley Robinson, Mark C Enright, et al.
Microbiology (Reading, England)|August 27, 1999
Serotype 14 variants of the Spanish penicillin-resistant serotype 9V clone of Streptococcus pneumoniae arose by large recombinational replacements of the cpsA-pbp1a regionTracey J Coffey, Margaret Daniels, Mark C Enright, et al.
Infection and Immunity|March 16, 2002
Influence of recombination and niche separation on the population genetic structure of the pathogen Streptococcus pyogenesAwdhesh Kalia, Brian G Spratt, Mark C Enright, et al.
Expert Review of Anti-Infective Therapy|September 13, 2011
Bacteriophage therapy: potential uses in the control of antibiotic-resistant pathogensBen Burrowes, David R Harper, Joseph Anderson, et al.
Emerging Infectious Diseases|June 18, 2004
Vancomycin susceptibility within methicillin-resistant Staphylococcus aureus lineagesRobin A Howe, Alastair Monk, Mandy Wootton, et al.
Antimicrobial Agents and Chemotherapy|April 28, 2005
Seven novel variants of the staphylococcal chromosomal cassette mec in methicillin-resistant Staphylococcus aureus isolates from IrelandAnna Shore, Angela S Rossney, Conor T Keane, et al.
Antimicrobial Agents and Chemotherapy|October 25, 2003
Related clones containing SCCmec type IV predominate among clinically significant Staphylococcus epidermidis isolatesHilmar Wisplinghoff, Adriana E Rosato, Mark C Enright, et al.
The Journal of Antimicrobial Chemotherapy|December 2, 2005
In vitro activity of a novel compound, the metal ion chelating agent AQ+, against clinical isolates of Staphylococcus aureusBenjamin R D Short, Miguel A Vargas, Jonathan C Thomas, et al.
Journal of Molecular and Genetic Medicine : an International Journal of Biomedical Research|August 9, 2012
The role of regulated clinical trials in the development of bacteriophage therapeuticsHelena Mrt Parracho, Ben H Burrowes, Mark C Enright, et al.
Journal of Bacteriology|December 3, 2005
Evolutionary genetics of the accessory gene regulator (agr) locus in Staphylococcus aureusD Ashley Robinson, Alastair B Monk, Jessica E Cooper, et al.
Pageof 6